Professor Mel Greaves thanks those who have donated to help us make childhood leukaemia preventable.
Dr Olivia Rossanese talks about our new drug access report – From Patent to Patient – and whether or not new cancer drugs are reaching cancer patients fast enough.
We spoke to Anne and heard about her ovarian cancer story and experiences with cancer drug olaparib.
Debbie Keynes spoke to us about her experience of being diagnosed with melanoma and subsequent treatment with cancer drug dabrafenib.
We spoke to Christine, who has secondary breast cancer, about her experience with the innovative new drug palbociclib.
We met Rob Lester who told us about his experience of being treated for advanced prostate cancer with abiraterone - a drug discovered by the ICR.
Our latest research shows that within the next decade, we can make acute lymphoblastic leukaemia (ALL) preventable. Your support will help us make this disease a thing of the past.
Professor Clare Isacke reveals she will be co-chairing the anniversary NCRI conference in 2019.
First-year PhD student, Anabel Zelceski, offers her thoughts on studying at a world-leading cancer research organisation.